ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
allogene
Allogene Therapeutics is seeking a contract Technical Lead to provide technical leadership for the development and improvement of manufacturing processes for gene delivery and gene editing materials used in allogeneic cell therapies. The role will collaborate with internal teams and external CDMOs across the product lifecycle, from early‑stage development through commercial manufacturing readiness, and will support assay development, process characterization, and regulatory activities.
Headquarters
South San Francisco, California, United States
Company Size
201-500 employees
Founded
2017
Allogene is a clinical-stage biotechnology company developing off-the-shelf AlloCAR T cell therapies using multiplex gene engineering and gene-editing to create allogeneic (ready-made) CAR T candidates. The company pairs a proprietary lymphodepletion approach with scalable, state-of-the-art manufacturing to optimize safety, durability, and broader patient access. Lead programs include cemacabtagene ansegedleucel (cema‑cel) for large B‑cell lymphoma (including frontline DLBCL), ALLO‑316 for renal cell carcinoma, and ALLO‑329 for autoimmune disease, alongside a broader pipeline. Allogene’s platform strategy aims to accelerate delivery of cell therapies by removing patient-specific manufacturing constraints.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for allogene.
10% below the average for this role
Director Technology Development Research
Kyowa Kirin
CART Scientist
Artech
Scientist II
CRISPR Therapeutics
Senior Scientist, Allogeneic T-Cell Therapy Process Development: Cell Therapy CMC
AstraZeneca
Director, Analytical Chemistry Extended Characterization
Eli Lilly and Company
Research Associate in Cell Biology
colossalbiosciences.com